GL1X · GenesisL1 explorer

MolNFT v1 · #39349 · protein

1.7 ångström structure of human ferrochelatase variant R115L

2HRC: “1.7 ångström structure of human ferrochelatase variant R115L”. X-ray diffraction, 3 ligands (CHD, FES, CL), 11 pockets (best druggability 0.79). MolNFT v1 #39349 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2HRC
Type
protein
Length
718 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ferrochelatase
EC
4.99.1.1
UniProt
P22830
Ligands
CHD, FES, CL
Pockets
11 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BFerrochelatase (EC 4.99.1.1)protein35949% helix, 14% strandP22830

Ligands and binding sites

  • CHD · Cholic acid · ligand · 6 copies · chains A, B
  • FES · Fe2/s2 (inorganic) cluster · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · 2 copies · chains A, B
  • IMD · Imidazole · additive · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11070.790.9830GOL
27460.780.8281CL, FES, IMD, CHD
36080.750.8248CL, IMD, CHD
4830.650.9128FES
52880.610.7928empty

Interfaces

1 interface between chains.

  • A–B · 1868 Ų buried · 32 hydrogen bonds · protein-protein

Compared structures

  • 2HRC · 1.7 angstrom structure of human ferrochelatase variant R115L · the same entry in another collection · chain A against A, TM-score 1.00
  • P22830 · AlphaFold monomer V2.0 prediction for ferrochelatase, mitochondrial (P22830) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.